Literature DB >> 30854958

Significance and Mechanisms of P-glycoprotein in Central Nervous System Diseases.

Liangliang Huang1, Binbin Li1, Xiang Li1, Ge Liu1, Rui Liu1, Jia Guo2, Baohui Xu2, Yunman Li1, Weirong Fang1.   

Abstract

P-glycoprotein (P-gp) is a member of ATP-Binding Cassette (ABC) transporter family. Because of its characteristic luminal surface location, high transport potency and structural specificity, Pgp is regarded as a selective gatekeeper of the Blood Brain Barrier (BBB) to prevent the entry of toxins or unwanted substances into the brain. In recent years, increasing evidence has shown that P-gp is involved in the immune inflammatory response in the Central Nervous System (CNS) disorders by regulating microglia activation, and mediating immune cell migration. Furthermore, Glucocorticoid Receptor (GR) may play a crucial role in P-gp-mediated microglia activation and immune cell migration via GR-mediated mRNA decay. In this article, we will review P-gp structure, distribution, function, regulatory mechanisms, inhibitors and effects of P-gp in the pathogenesis of several CNS diseases and will discuss the role of P-gp in microglia activation, immune cell migration and the relationship with cytokine secretion. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  P-glycoprotein; central nervous system; chemokine (C-Czzm321990motif) ligand 2; glucocorticoid receptor; immune inflammation; microglia.

Mesh:

Substances:

Year:  2019        PMID: 30854958     DOI: 10.2174/1389450120666190308144448

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  3 in total

Review 1.  The Blood-Brain Barrier-A Key Player in Multiple Sclerosis Disease Mechanisms.

Authors:  Thomas Gabriel Schreiner; Constantin Romanescu; Bogdan Ovidiu Popescu
Journal:  Biomolecules       Date:  2022-04-02

Review 2.  Pitfalls of Antiretroviral Therapy: Current Status and Long-Term CNS Toxicity.

Authors:  Harrison Rudd; Michal Toborek
Journal:  Biomolecules       Date:  2022-06-26

Review 3.  Glioblastoma, from disease understanding towards optimal cell-based in vitro models.

Authors:  Chiara Boccellato; Markus Rehm
Journal:  Cell Oncol (Dordr)       Date:  2022-06-28       Impact factor: 7.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.